Assessing the effectiveness of text enhancements to prevent drug name confusion errors

Active Definitive Contract Awarded Last action

Contract number
75F40122C00191
Awardee
Awarding agency
Obligated
$1,184,888

Award facts

Contract value 45% obligated
  • $1,184,887.97 Current, with exercised options
  • $2,656,574.97 Potential, with all options
Completion date 82% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost No Fee
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 · EO 14398 - assessing the effectiveness of text enhancements to prevent drug name confusion errors. NCE $0
Change Order P00002 $0
Funding Only Action P00001 $368
Original award $1,184,520

About this award

The Food and Drug Administration awarded a $2.656 million definitive contract to Northwestern University for assessing the effectiveness of text enhancements to prevent drug name confusion errors on September 21, 2022, under a cost-no-fee pricing structure.

The originating effort supports Executive Order 14398 and addresses medication safety through research into text enhancement strategies that reduce drug name confusion errors. Place of performance is Silver Spring, MD. The contract extends through September 29, 2027.

Northwestern University subcontracted elements of the work to the University of Illinois (award dates February 22, 2024 and March 17, 2026) and the Institute for Safe Medication Practices (award date February 9, 2024).

Subawards

Subcontractor Amount Awarded
Institute For Safe Medication Practices ASSESSING THE EFFECTIVENESS OF TEXT ENHANCEMENTS TO PREVENT DRUG NAME CONFUSION ERRORS Assessing the Effectiveness of Text Enhancements to Prevent Drug Name… $35,899
University Of Illinois ASSESSING THE EFFECTIVENESS OF TEXT ENHANCEMENTS TO PREVENT DRUG NAME CONFUSION ERRORS Assessing the Effectiveness of Text Enhancements to Prevent Drug Name… $20,406
University Of Illinois ASSESSING THE EFFECTIVENESS OF TEXT ENHANCEMENTS TO PREVENT DRUG NAME CONFUSION ERRORS Assessing the Effectiveness of Text Enhancements to Prevent Drug Name… $4,369
Institute For Safe Medication Practices ASSESSING THE EFFECTIVENESS OF TEXT ENHANCEMENTS TO PREVENT DRUG NAME CONFUSION ERRORS AIM 1-Assessing the Effectiveness of Text Enhancements to Prevent Drug… $5,801

Quick answers

Who was awarded contract 75F40122C00191?

75F40122C00191 was awarded to Northwestern University by Food and Drug Administration (Department of Health and Human Services) on September 21, 2022.

How much is contract 75F40122C00191 worth?

The government has obligated $1,184,888 on 75F40122C00191. Its potential value, with all options, is $2,656,575.

Was contract 75F40122C00191 competed?

The extent of competition for 75F40122C00191 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award